In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology
Introduction
Application of absorption-enhancing agents as formulation excipients to improve the oral bioavailability (BA) of biopharmaceuticals has remained an active area of research in drug delivery technology (Lee et al., 1991, Aungst, 1996). In recent years, particular attention has been given to enhancing agents that are endogenous and/or metabolizable by mucosal tissues (Fix, 1987, Muranishi, 1990, Chao et al., 1998a). As a good example, sodium salts of medium-chain fatty acids, sodium caprate (C10) in particular, have been shown to promote the transmucosal absorption of drugs and marker compounds (Tomita et al., 1992, Lindmark et al., 1998, Shimazaki et al., 1998), apparently mainly by enhancing the permeabilities of the paracellular pathway (Sawada et al., 1991, Anderberg et al., 1993). C10 is a dairy product constituent that has been approved in a few countries for use in humans as an absorption-enhancing agent (Watts and Illum, 1997).
It seems that so far most of the published studies on effects of C10 on intestinal permeabilities have involved in vitro transport analysis of small-molecule, non-peptide marker compounds. Also, data are sparse regarding the in vitro and in vivo effect of C10 on morphology/viability of the mucosal epithelial tissues. To complement the information available in the literature, in the present study we conducted both in vitro and in vivo investigations of effects of C10 on intestinal absorption of model compounds including a peptidase-resistant model decapeptide, and on mucosal morphology. Our results show that C10, when co-administered as a formulation excipient, can effectively enhance the intestinal absorption of small peptide and other small-molecule compounds without causing significant morphological alterations of the gastrointestinal (GI) mucosa.
Section snippets
Materials
Caco-2 cells were purchased from American Type Culture Collection (Rockville, MD). Male Sprague–Dawley rats were from Charles River (Wilmington, MD). Cell culture media and reagents were from Life Technologies (Grand Island, NY). Fetal bovine serum was from HyClone Laboratories (Logan, UT). Synthetic d-decapeptide (constituent amino acid sequence: d-Glu-d-Tyr-d-Leu-d-Lys-d-Ala-d-Leu-d-Leu-d-Ser-d-Lys-d-Leu-NH2) and d-[3H]decapeptide (35 Ci/mmol) were from Cambridge Research Biochemicals
Effect of C10 on the TEER of Caco-2 cell monolayers
The effect of C10 on the in vitro permeability of intestinal epithelium and the reversibility of this effect were first examined electrophysiologically by monitoring the TEER values of cultures of Caco-2 cells. The baseline TEER of the Caco-2 monolayers was 244±8 (S.E.) Ω-cm2 (n=28). As shown in Fig. 1, the mucosal addition of C10 in the concentration range of 13–25 mM quickly reduced the Caco-2 TEER by 40–65%, with a T1/2 (the time required to show the half-maximal effect of C10) of ∼5 min.
Discussion
Mucosal addition of C10 rapidly reduced the Caco-2 TEER (T1/2, ∼5 min) and, upon its washout, a marked propensity for recovery of TEER was observed. This result is in concert with the recent finding by Söderholm et al. (1998) that apical C10 causes a reversible drop in VE and increases in vitro EDTA permeation across rat ileum, and suggests that C10 does not cause long-term damage to the Caco-2 monolayer and that its effect on Caco-2 permeability is reversible.
To study the effect of C10 on
Acknowledgements
We wish to thank Dr Patrick Wong and Dr Liang Dong (Oral Products R&D, ALZA Corporation, USA) for their helpful discussions.
References (20)
- et al.
Epithelial transport of drugs in cell culture. VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells
J. Pharm. Sci.
(1993) - et al.
Niflumic and flufenamic acids are potent inhibitors of chloride secretion in mammalian airway
Life Sci.
(1992) - et al.
Enhancement of intestinal model compound transport by DS-1, a modified Quillaja saponin
J. Pharm. Sci.
(1998) Absorption enhancing agents for the GI system
J. Controlled Release
(1987)- et al.
Effects of sodium salicylate on epithelial cells of the rectal mucosa of the rat: a light and electron microscopic study
Life Sci.
(1983) - et al.
Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route
Pharm. Res.
(1993) Oral mucosal permeation enhancement: possibilities and limitations
- et al.
Molecular weight-dependent paracellular transport of fluorescent model compounds induced by palmitoylcarnitine chloride across the human intestinal cell line Caco-2
J. Drug Target.
(1998) - et al.
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption
Crit. Rev. Ther. Drug Carrier Syst.
(1991) - et al.
Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate
Pharm. Res.
(1997)
Cited by (0)
- 1
Present address: Eli Lilly and Company, Lilly Corporate Center, Drop Code 6414, Indianapolis, Indiana 46285, USA.
- 2
Present address: Stanford Research Center, Yamanouchi-Shaklee Pharma, Palo Alto, CA 94304, USA.